ARCHIVES

Drug Company Cries Foul Over Clams Of Taxotere’s Superiority To Taxol

This article is from The Cancer Letter archive.

Vol. 19 No. 24 | June 11, 1993

Download PDF Visit The Full Archive

Related Articles

Compendia Publishers Must Tell CMS How They Manage Conflicts Of Interest

November 13, 2009

Long-Term Effect Of One Phase III Trial: Benefit For Thousands Of Patients

November 27, 2009

IOM Report: Seek More Comment From Public On Priorities, NIH Told

July 17, 1998

Funding Opportunities: NCI Grant Supplements For Mammalian Models

October 22, 1999

NCI Comprehensive Center List Omits Georgetown/Howard, Adds Arizona

June 1, 1990

IOM Calls for Freeze On Med School Classes, Cuts of Residencies

February 2, 1996